Courtagen Life Sciences Announced Today the Launch of New Tests for … – Business Wire (press release)
Courtagen Life Sciences Announced Today the Launch of New Tests for …Business Wire (press release)The new tests will complement the current nucSEEK® Comprehensive Nuclear Mitochondrial Exome Panel and epiSEEK® Comprehensive Epilepsy and Seizure Disorder Panel, respectively. Physicians will now have more flexibility to … “Our new nucSEEK® Focus …and more »
[monetize id=”1″]
[monetize id=”2″]
Scientists Win $3.3 Million Grant to Speed Development of Treatments for Intellectual Disability, Autism, Epilepsy
Scientists from the Florida campus of The Scripps Research Institute have been awarded $3.3 million by the National Institutes of Health to identify biomarkers to accelerate drug development for disorders including autism spectrum disorder, epilepsy and some types of intellectual disability.
